Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Ordinary Shares, $0.0001 par value
-
Shares outstanding
-
172,779,139
-
Total 13F shares
-
42,586,066
-
Share change
-
+9,722,259
-
Total reported value
-
$1,736,374,072
-
Put/Call ratio
-
15%
-
Price per share
-
$40.76
-
Number of holders
-
121
-
Value change
-
+$365,354,803
-
Number of buys
-
83
-
Number of sells
-
40
Institutional Holders of Structure Therapeutics Inc. - Ordinary Shares, $0.0001 par value (GPCR) as of Q4 2023
As of 31 Dec 2023,
Structure Therapeutics Inc. - Ordinary Shares, $0.0001 par value (GPCR) was held by
121 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
42,586,066 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, Avoro Capital Advisors LLC, FEDERATED HERMES, INC., TCG Crossover Management, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., PRICE T ROWE ASSOCIATES INC /MD/, JANUS HENDERSON GROUP PLC, and T. Rowe Price Investment Management, Inc..
This page lists
121
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.